These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10086969)

  • 21. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry.
    Occhetta E; Bortnik M; Vassanelli C;
    Europace; 2003 Apr; 5(2):153-62. PubMed ID: 12633640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data.
    Liao Y; Li X; Zhang Y; Chen S; Tang C; Du J
    Acta Paediatr; 2009 Jul; 98(7):1194-200. PubMed ID: 19397534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    Baron-Esquivias G; Morillo CA; Moya-Mitjans A; Martinez-Alday J; Ruiz-Granell R; Lacunza-Ruiz J; Garcia-Civera R; Gutierrez-Carretero E; Romero-Garrido R
    J Am Coll Cardiol; 2017 Oct; 70(14):1720-1728. PubMed ID: 28958328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.
    Connolly SJ; Sheldon R; Roberts RS; Gent M
    J Am Coll Cardiol; 1999 Jan; 33(1):16-20. PubMed ID: 9935002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit of dual-chamber pacing with Closed Loop Stimulation in tilt-induced cardio-inhibitory reflex syncope (BIOSync trial): study protocol for a randomized controlled trial.
    Brignole M; Tomaino M; Aerts A; Ammirati F; Ayala-Paredes FA; Deharo JC; Del Rosso A; Hamdan MH; Lunati M; Moya A; Gargaro A;
    Trials; 2017 May; 18(1):208. PubMed ID: 28472974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Cholewa M
    Ann Noninvasive Electrocardiol; 2005 Jan; 10(1):65-72. PubMed ID: 15649240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midodrine: a role in the management of neurocardiogenic syncope.
    Ward CR; Gray JC; Gilroy JJ; Kenny RA
    Heart; 1998 Jan; 79(1):45-9. PubMed ID: 9505918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents.
    Zhang Q; Jin H; Wang L; Chen J; Tang C; Du J
    Med Sci Monit; 2008 Apr; 14(4):CR199-203. PubMed ID: 18376348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
    Flevari P; Livanis EG; Theodorakis GN; Zarvalis E; Mesiskli T; Kremastinos DT
    J Am Coll Cardiol; 2002 Aug; 40(3):499-504. PubMed ID: 12142117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of atropine in vasovagal syncope induced by head-up tilt testing.
    Santini M; Ammirati F; Colivicchi F; Gentilucci G; Guido V
    Eur Heart J; 1999 Dec; 20(23):1745-51. PubMed ID: 10562483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.
    Sheldon R; Rose S; Connolly S
    Europace; 2003 Jan; 5(1):71-5. PubMed ID: 12504644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
    Sheldon R; Connolly S;
    Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope.
    Ammirati F; Colivicchi F; Toscano S; Pandozi C; Laudadio MT; De Seta F; Santini M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2178-81. PubMed ID: 9825314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial).
    van Dijk N; Quartieri F; Blanc JJ; Garcia-Civera R; Brignole M; Moya A; Wieling W;
    J Am Coll Cardiol; 2006 Oct; 48(8):1652-7. PubMed ID: 17045903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study.
    Russo V; Rago A; Papa AA; Golino P; Calabrò R; Russo MG; Nigro G
    Heart; 2013 Nov; 99(21):1609-13. PubMed ID: 23723446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tilt training: does it have a role in preventing vasovagal syncope?
    Gurevitz O; Barsheshet A; Bar-Lev D; Zimlichman E; Rosenfeld GF; Benderly M; Luria D; Amital H; Kreiss Y; Eldar M; Glikson M
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1499-505. PubMed ID: 18070305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Midodrine hydrochloride in the treatment of vasovagal syncope.
    Mitro P; Trejbal D; Rybár AR
    Pacing Clin Electrophysiol; 1999 Nov; 22(11):1620-4. PubMed ID: 10598965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.